Risk Factors for Treatment Failure with Antiosteoporosis Medication: The Global Longitudinal Study of Osteoporosis in Women (GLOW)

Anti-osteoporosis medication (AOM) does not abolish fracture risk, and some individuals experience multiple fractures while on treatment. Therefore, criteria for treatment failure have recently been defined. Using data from the Global Longitudinal study of Osteoporosis in Women (GLOW), we analyzed r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Bone Miner Res
Main Authors: Díez-Pérez, Adolfo, Adachi, Jonathan D, Adami, Silvano, Anderson, Frederick A, Boonen, Steven, Chapurlat, Roland, Compston, Juliet E, Cooper, Cyrus, Gehlbach, Stephen H, Greenspan, Susan L, Hooven, Frederick H, LaCroix, Andrea Z, Nieves, Jeri W, Netelenbos, J Coen, Pfeilschifter, Johannes, Rossini, Maurizio, Roux, Christian, Saag, Kenneth G, Silverman, Stuart, Siris, Ethel S, Wyman, Allison, Rushton-Smith, Sophie K, Watts, Nelson B
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4878143/
https://ncbi.nlm.nih.gov/pubmed/23794198
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.2023
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados